Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations.

Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20

Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation (2007) 4.37

A rabbit ventricular action potential model replicating cardiac dynamics at rapid heart rates. Biophys J (2008) 4.22

Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature (2011) 4.10

Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm (2010) 2.79

Calcium and arrhythmogenesis. Physiol Rev (2007) 2.76

Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet (2013) 2.63

Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Annu Rev Cell Dev Biol (2008) 2.40

Proarrhythmic defects in Timothy syndrome require calmodulin kinase II. Circulation (2008) 2.16

Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet (2013) 2.09

Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci (2010) 2.00

The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc Natl Acad Sci U S A (2008) 1.95

Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome. Circ Cardiovasc Genet (2013) 1.93

Kinetic properties of the cardiac L-type Ca2+ channel and its role in myocyte electrophysiology: a theoretical investigation. Biophys J (2006) 1.71

Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat Neurosci (2013) 1.68

Genome-wide association analysis identifies multiple loci related to resting heart rate. Hum Mol Genet (2010) 1.67

The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation. J Physiol (2008) 1.61

Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ Res (2012) 1.61

A putative cation channel, NCA-1, and a novel protein, UNC-80, transmit neuronal activity in C. elegans. PLoS Biol (2008) 1.61

Mechanisms of specificity in neuronal activity-regulated gene transcription. Prog Neurobiol (2011) 1.49

Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels. Pflugers Arch (2010) 1.45

Inherited calcium channelopathies in the pathophysiology of arrhythmias. Nat Rev Cardiol (2012) 1.44

Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes. J Mol Cell Cardiol (2014) 1.42

Pro- and antiarrhythmic effects of ATP-sensitive potassium current activation on reentry during early afterdepolarization-mediated arrhythmias. Heart Rhythm (2012) 1.42

CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol (2012) 1.40

The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacol Rev (2015) 1.38

Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). Eur Heart J (2011) 1.37

Modifying L-type calcium current kinetics: consequences for cardiac excitation and arrhythmia dynamics. Biophys J (2008) 1.30

Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol (2012) 1.28

Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues. Pharmacogenet Genomics (2006) 1.27

A mitochondrial bioenergetic etiology of disease. J Clin Invest (2013) 1.27

Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine. Heart Rhythm (2007) 1.27

CaV1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency. Pflugers Arch (2009) 1.26

Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc Natl Acad Sci U S A (2011) 1.26

Molecular and genetic basis of sudden cardiac death. J Clin Invest (2013) 1.23

Autonomic nerve stimulation reverses ventricular repolarization sequence in rabbit hearts. Circ Res (2007) 1.22

Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2. Crit Rev Biochem Mol Biol (2012) 1.20

Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins. Mol Cell Biol (2009) 1.20

Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet (2014) 1.17

Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjects. Br J Clin Pharmacol (2006) 1.16

Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. J Am Coll Cardiol (2012) 1.15

Control of neuronal voltage-gated calcium ion channels from RNA to protein. Trends Neurosci (2013) 1.13

Genetic mechanisms of atrial fibrillation: impact on response to treatment. Nat Rev Cardiol (2013) 1.11

Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome. J Mol Cell Cardiol (2009) 1.11

Long QT, syndactyly, joint contractures, stroke and novel CACNA1C mutation: expanding the spectrum of Timothy syndrome. Am J Med Genet A (2011) 1.11

Genetically induced dysfunctions of Kir2.1 channels: implications for short QT3 syndrome and autism-epilepsy phenotype. Hum Mol Genet (2014) 1.08

Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation. J Biol Chem (2009) 1.08

Disruption of the IS6-AID linker affects voltage-gated calcium channel inactivation and facilitation. J Gen Physiol (2009) 1.08

Phospholemman modulates the gating of cardiac L-type calcium channels. Biophys J (2010) 1.08

Molecular endpoints of Ca2+/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels. J Gen Physiol (2010) 1.07

L-type Ca(2+) channels in heart and brain. Wiley Interdiscip Rev Membr Transp Signal (2014) 1.06

HERG1 channelopathies. Pflugers Arch (2009) 1.06

Assembly of functionally integrated human forebrain spheroids. Nature (2017) 1.05

Computer modeling of siRNA knockdown effects indicates an essential role of the Ca2+ channel alpha2delta-1 subunit in cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A (2007) 1.05

Targeting voltage-gated calcium channels in neurological and psychiatric diseases. Nat Rev Drug Discov (2015) 1.02

Genotype- and phenotype-guided management of congenital long QT syndrome. Curr Probl Cardiol (2013) 1.01

MicroRNA regulation of cardiac conduction and arrhythmias. Transl Res (2012) 1.01

Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein. J Biol Chem (2011) 1.01

GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease. BMC Cardiovasc Disord (2011) 0.99

Recent progress in congenital long QT syndrome. Curr Opin Cardiol (2010) 0.99

A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain. Mol Psychiatry (2013) 0.99

Small GTPase Rab11b regulates degradation of surface membrane L-type Cav1.2 channels. Am J Physiol Cell Physiol (2011) 0.98

Channelopathy pathogenesis in autism spectrum disorders. Front Genet (2013) 0.97

An approach based on a genome-wide association study reveals candidate loci for narcolepsy. Hum Genet (2010) 0.96

Cooperative regulation of Ca(v)1.2 channels by intracellular Mg(2+), the proximal C-terminal EF-hand, and the distal C-terminal domain. J Gen Physiol (2009) 0.96

Modeling Timothy syndrome with iPS cells. J Cardiovasc Transl Res (2013) 0.95

Long QT syndrome in South Africa: the results of comprehensive genetic screening. Cardiovasc J Afr (2013) 0.94

Alternative splicing of voltage-gated calcium channels: from molecular biology to disease. Pflugers Arch (2009) 0.94

Redox control of cardiac excitability. Antioxid Redox Signal (2012) 0.94

Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individuals. Life Sci (2009) 0.94

Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium. J Cell Mol Med (2011) 0.94

Phosphorylation sites required for regulation of cardiac calcium channels in the fight-or-flight response. Proc Natl Acad Sci U S A (2013) 0.93

L-type calcium channel targeting and local signalling in cardiac myocytes. Cardiovasc Res (2013) 0.93

Novel Timothy syndrome mutation leading to increase in CACNA1C window current. Heart Rhythm (2014) 0.92

Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases. Circulation (2012) 0.91

CaMKII associates with CaV1.2 L-type calcium channels via selected beta subunits to enhance regulatory phosphorylation. J Neurochem (2009) 0.91

Interplay of voltage and Ca-dependent inactivation of L-type Ca current. Prog Biophys Mol Biol (2010) 0.89

Calcium signalling and calcium transport in bone disease. Subcell Biochem (2007) 0.89

Genetics of long QT syndrome. Methodist Debakey Cardiovasc J (2014) 0.89

A rare association of long QT syndrome and syndactyly: Timothy syndrome (LQT 8). Clin Res Cardiol (2011) 0.89

Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility. Prog Biophys Mol Biol (2012) 0.89

Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death. Circ Arrhythm Electrophysiol (2015) 0.89

Cardiac gene defects can cause sudden cardiac death in young people. Dtsch Arztebl Int (2009) 0.89

Cardiac arrhythmias and sudden death in infancy: implication for the medicolegal investigation. Int J Legal Med (2006) 0.88

A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels. PLoS Genet (2008) 0.88

A CACNA1C variant associated with reduced voltage-dependent inactivation, increased CaV1.2 channel window current, and arrhythmogenesis. PLoS One (2014) 0.88

What can naturally occurring mutations tell us about Ca(v)1.x channel function? Biochim Biophys Acta (2012) 0.87

Multilayered regulation of cardiac ion channels. Biochim Biophys Acta (2012) 0.87

Graded Ca²⁺/calmodulin-dependent coupling of voltage-gated CaV1.2 channels. Elife (2015) 0.87

Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies. Appl Clin Genet (2013) 0.87

Oxidative inactivation of the lipid phosphatase phosphatase and tensin homolog on chromosome ten (PTEN) as a novel mechanism of acquired long QT syndrome. J Biol Chem (2010) 0.86

Calcineurin Controls Voltage-Dependent-Inactivation (VDI) of the Normal and Timothy Cardiac Channels. Sci Rep (2012) 0.86

Molecular alteration of Ca(v)1.2 calcium channel in chronic myocardial infarction. Pflugers Arch (2009) 0.86

A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long QT Syndrome. Circ Res (2016) 0.85

Ca²⁺ channels and praziquantel: a view from the free world. Parasitol Int (2012) 0.85

Divergent biophysical properties, gating mechanisms, and possible functions of the two skeletal muscle Ca(V)1.1 calcium channel splice variants. J Muscle Res Cell Motil (2011) 0.85

Cellular mechanisms of ventricular arrhythmias in a mouse model of Timothy syndrome (long QT syndrome 8). J Mol Cell Cardiol (2013) 0.85

Introduction into Ca(v)2.1 of the homologous mutation of Ca(v)1.2 causing the Timothy syndrome questions the role of V421 in the phenotypic definition of P-type Ca(2+) channel. Pflugers Arch (2008) 0.85

Neutralisation of a single voltage sensor affects gating determinants in all four pore-forming S6 segments of Ca(V)1.2: a cooperative gating model. Pflugers Arch (2012) 0.85

Molecular Pathophysiology of Congenital Long QT Syndrome. Physiol Rev (2017) 0.85

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell (1995) 11.62

The open pore conformation of potassium channels. Nature (2002) 9.09

The CpG dinucleotide and human genetic disease. Hum Genet (1988) 7.86

Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell (2004) 7.45

A dynamic model of the cardiac ventricular action potential. I. Simulations of ionic currents and concentration changes. Circ Res (1994) 6.93

Inactivation of calcium channels in mammalian heart cells: joint dependence on membrane potential and intracellular calcium. J Physiol (1985) 4.69

Electrophysiological recording from Xenopus oocytes. Methods Enzymol (1992) 3.64

Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol (2003) 3.10

Ionic basis of transient inward current induced by strophanthidin in cardiac Purkinje fibres. J Physiol (1978) 2.94

Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med (1997) 2.57

The amino-acid mutational spectrum of human genetic disease. Genome Biol (2003) 2.55

Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes. Mol Pharmacol (1990) 2.31

Novel functional properties of Ca(2+) channel beta subunits revealed by their expression in adult rat heart cells. J Physiol (2002) 2.18

Long QT syndrome associated with syndactyly identified in females. Am J Cardiol (1995) 1.93

A computational model of the human left-ventricular epicardial myocyte. Biophys J (2004) 1.88

Expression of ion channels by injection of mRNA into Xenopus oocytes. Methods Cell Biol (1991) 1.87

Sequence-function analysis of the K+-selective family of ion channels using a comprehensive alignment and the KcsA channel structure. Biophys J (2003) 1.79

Clinical and genetic heterogeneity in nemaline myopathy--a disease of skeletal muscle thin filaments. Trends Mol Med (2001) 1.76

A new form of long QT syndrome associated with syndactyly. J Am Coll Cardiol (1995) 1.47

[The heart-hand syndrome. A new variant of disorders of heart conduction and syndactylia including osseous changes in hands and feet]. Kinderarztl Prax (1992) 1.29

INaCa and ICl(Ca) contribute to isoproterenol-induced delayed after depolarizations in midmyocardial cells. Am J Physiol (1998) 1.22

Comparison of sodium-calcium exchanger and transient inward currents in single cells from rabbit ventricle. J Physiol (1989) 1.14

Triggered activity in the heart: cellular mechanisms of early after-depolarizations. Eur Heart J (1991) 1.12

Formation of the nemaline structures in soleus muscle of rats subjected to long-lasting immobilization. Folia Morphol (Warsz) (1999) 0.91

Heart regeneration in zebrafish. Science (2002) 10.45

Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell (2004) 7.45

Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA (2006) 5.10

Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science (2002) 4.40

Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation (2007) 4.37

Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med (2007) 3.98

p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev (2005) 3.88

Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A (2007) 3.72

International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev (2005) 3.50

Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet (2008) 3.29

Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet (2006) 3.17

Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm (2004) 3.15

ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet (2003) 3.12

Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood (2008) 3.05

Gene expression analysis of zebrafish heart regeneration. PLoS Biol (2006) 3.00

A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. Science (2011) 3.00

GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science (2012) 2.69

Tales of regeneration in zebrafish. Dev Dyn (2003) 2.63

Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A (2002) 2.60

Relation between the Widom line and the dynamic crossover in systems with a liquid-liquid phase transition. Proc Natl Acad Sci U S A (2005) 2.48

A critical role for elastin signaling in vascular morphogenesis and disease. Development (2003) 2.47

fgf20 is essential for initiating zebrafish fin regeneration. Science (2005) 2.43

Interactions between S4-S5 linker and S6 transmembrane domain modulate gating of HERG K+ channels. J Biol Chem (2002) 2.34

Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet (2005) 2.33

FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci U S A (2006) 2.30

Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J (2003) 2.30

Compound mutations: a common cause of severe long-QT syndrome. Circulation (2004) 2.29

De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res (2005) 2.27

Reproducibility of gene expression across generations of Affymetrix microarrays. BMC Bioinformatics (2003) 2.20

Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation (2002) 2.20

The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol Cell (2004) 2.19

Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest (2012) 2.15

Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology (2013) 2.09

Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish. Nat Chem Biol (2006) 2.08

Mps1 defines a proximal blastemal proliferative compartment essential for zebrafish fin regeneration. Development (2002) 2.05

The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update. Hum Mutat (2010) 2.03

The acid-sensitive potassium channel TASK-1 in rat cardiac muscle. Cardiovasc Res (2007) 2.00

A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A (2004) 1.98

Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation (2002) 1.95

An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95

GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region. Am J Med Genet A (2003) 1.94

Osteochondroma of the scapula associated with winging and large bursa formation. Med Princ Pract (2006) 1.93

KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain (2003) 1.92

Evolutionarily conserved gene family important for fat storage. Proc Natl Acad Sci U S A (2007) 1.91

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome. J Cardiovasc Electrophysiol (2003) 1.91

T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci U S A (2009) 1.83

Gating currents associated with intramembrane charge displacement in HERG potassium channels. Proc Natl Acad Sci U S A (2003) 1.82

A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells. Immunity (2009) 1.82

Anillin localization defect in cardiomyocyte binucleation. J Mol Cell Cardiol (2006) 1.78

A proliferation gradient between proximal and msxb-expressing distal blastema directs zebrafish fin regeneration. Development (2002) 1.76

RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br J Haematol (2004) 1.76

Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am J Hum Genet (2006) 1.73

Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiency. Hum Mol Genet (2009) 1.73

Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum (2007) 1.72

The exon 55 deletion in the nebulin gene--one single founder mutation with world-wide occurrence. Neuromuscul Disord (2009) 1.70

Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-ribosomal RNA processing defect in diamond-blackfan anemia. Hum Mutat (2012) 1.64

X-linked myotubular and centronuclear myopathies. J Neuropathol Exp Neurol (2005) 1.61

Voltage-dependent gating of hyperpolarization-activated, cyclic nucleotide-gated pacemaker channels: molecular coupling between the S4-S5 and C-linkers. J Biol Chem (2004) 1.60

Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. Am J Hum Genet (2012) 1.60

Normal newt limb regeneration requires matrix metalloproteinase function. Dev Biol (2005) 1.59

The pore structure and gating mechanism of K2P channels. EMBO J (2011) 1.56

Physicochemical features of the HERG channel drug binding site. J Biol Chem (2003) 1.54

Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1). Hum Mutat (2009) 1.54

IFN-inducible GTPases in host cell defense. Cell Host Microbe (2012) 1.53

The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem Biol (2006) 1.52

Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle alpha-actin. Neuromuscul Disord (2004) 1.52

Regulation of endocytic recycling of KCNQ1/KCNE1 potassium channels. Circ Res (2007) 1.52

The inhibition of the potassium channel TASK-1 in rat cardiac muscle by endothelin-1 is mediated by phospholipase C. Cardiovasc Res (2012) 1.51

Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels. Proc Natl Acad Sci U S A (2002) 1.51

Molecular determinants of HERG channel block. Mol Pharmacol (2006) 1.49

Novel features of the rabbit transverse tubular system revealed by quantitative analysis of three-dimensional reconstructions from confocal images. Biophys J (2008) 1.47

Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy. Am J Hum Genet (2013) 1.46

Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells (2006) 1.46

AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum Mol Genet (2008) 1.44

Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol Pharmacol (2005) 1.43

Heterogeneous three-dimensional anatomical and electrophysiological model of human atria. Philos Trans A Math Phys Eng Sci (2006) 1.39

Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond-Blackfan anemia. Hum Genet (2013) 1.39

Verification of cardiac tissue electrophysiology simulators using an N-version benchmark. Philos Trans A Math Phys Eng Sci (2011) 1.37

Synthesis, antimicrobial and antiviral evaluation of substituted imidazole derivatives. Eur J Med Chem (2008) 1.36

CACNA1H mutations in autism spectrum disorders. J Biol Chem (2006) 1.35

Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block. J Biol Chem (2002) 1.33

Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator. Proc Natl Acad Sci U S A (2007) 1.32

Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy. Sci Transl Med (2014) 1.32

Activin-betaA signaling is required for zebrafish fin regeneration. Curr Biol (2007) 1.31

Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels. J Biol Chem (2003) 1.30

The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel. Proc Natl Acad Sci U S A (2008) 1.30

The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies. Hum Mol Genet (2011) 1.30

Transcriptional profiling of caudal fin regeneration in zebrafish. ScientificWorldJournal (2006) 1.30

Cardiac cell modelling: observations from the heart of the cardiac physiome project. Prog Biophys Mol Biol (2010) 1.29